Financials in USD. Standardized financial statements.
A compact view of how aTyr Pharma, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $190,000 | $235,000 | $353,000 | $10.39M | $0 | $10.46M | $422,000 | $0 | $0 | $0 |
| Revenue Growth? | -19.1% | -33.4% | -96.6% | 0.0% | -100.0% | +2377.5% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $1.55M | $0 | $0 | $1.70M | $1.30M | $17.29M | $14.05M | $746,000 | $713,000 | $900,000 |
| Gross Profit? | -$1.36M | $235,000 | $353,000 | $8.69M | -$1.30M | -$6.84M | -$13.63M | -$746,000 | -$713,000 | -$900,000 |
| Gross Margin? | -717.4% | +100.0% | +100.0% | +83.7% | 0.0% | -65.4% | -3228.9% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $76.26M | $68.15M | $55.27M | $55.09M | $32.71M | $9.07M | $9.35M | $32.07M | $46.43M | $58.44M |
| Operating Income? | -$77.63M | -$67.91M | -$54.92M | -$46.40M | -$34.02M | -$15.91M | -$22.98M | -$32.82M | -$47.15M | -$59.34M |
| EBITDA? | -$76.07M | -$66.37M | -$52.18M | -$44.71M | -$32.47M | -$14.64M | -$22.34M | -$32.07M | -$46.43M | -$57.00M |
| Income Before Tax | -$74.12M | -$64.02M | -$50.40M | -$45.34M | -$33.78M | -$16.23M | -$23.76M | -$34.52M | -$48.21M | -$57.90M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$49,000 |
| Net Income? | -$74.12M | -$64.02M | -$50.39M | -$45.34M | -$33.77M | -$16.22M | -$23.60M | -$34.52M | -$48.21M | -$57.85M |
| EPS? | $-0.80 | $-0.86 | $-0.94 | $-1.60 | $-1.77 | $-1.77 | $-7.03 | $-16.13 | $-26.16 | $-34.20 |
| Diluted EPS? | $-0.80 | $-0.86 | $-0.94 | $-1.60 | $-1.77 | $-1.77 | $-7.03 | $-16.13 | $-26.16 | $-34.20 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality